Literature DB >> 28861172

Hepatocyte growth factor induces breast cancer cell invasion via the PI3K/Akt and p38 MAPK signaling pathways to up-regulate the expression of COX2.

Wenbin Kuang1, Qiuchan Deng1,2, Chuntao Deng3, Wensheng Li4, Shaowei Shu1, Meirong Zhou1.   

Abstract

Hepatocyte growth factor (HGF) is a multifunctional growth factor that plays important roles in promoting the invasion and metastasis of various tumor cells. However, there are few reports about the exact mechanisms of HGF involved in the regulation of cell invasion via the induction of COX2. In this study, we found that HGF could activate its receptor c-Met and up-regulate COX2 expression in a dose- and time-dependent manner, which resulted in an increase in MMP-9 expression and subsequent invasiveness of the breast cancer cell lines MDA-MB-231 and MCF-7. The HGF-induced expression of COX2 and MMP-9 and cell invasion were partially suppressed by COX2 gene silencing. The PI3K/Akt and p38 MAPK signaling pathways were activated by HGF in both cell lines. However, PI3K/Akt or p38 MAPK-specific inhibition alone partially attenuated HGF-induced COX2 and MMP-9 expression and the invasiveness of the two breast cancer cell lines, and these HGF-induced effects were almost completely abolished by simultaneous treatment with both inhibitors. Therefore, we concluded that HGF mediates the up-regulation of COX2 predominantly through the PI3K/Akt and p38 MAPK signaling pathways, leading to MMP-9 expression and the subsequent invasion of two breast cancer cell lines. This study improves our understanding of the signal transduction mechanisms in the HGF-induced invasion and progression of breast cancer.

Entities:  

Keywords:  Hepatocyte growth factor (HGF); PI3K/Akt; breast cancer; cyclooxygenase 2 (COX2); invasion; metalloproteinase-9 (MMP9); p38 MAPK

Year:  2017        PMID: 28861172      PMCID: PMC5575195     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  35 in total

Review 1.  Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition.

Authors:  Daniel L Simmons; Regina M Botting; Timothy Hla
Journal:  Pharmacol Rev       Date:  2004-09       Impact factor: 25.468

2.  Prostaglandin-endoperoxide H synthase-2 expression in human thyroid epithelium. Evidence for constitutive expression in vivo and in cultured KAT-50 cells.

Authors:  T J Smith; T A Jennings; D Sciaky; H J Cao
Journal:  J Biol Chem       Date:  1999-05-28       Impact factor: 5.157

3.  Role of COX-2 in tumorospheres derived from a breast cancer cell line.

Authors:  Balraj Singh; Kendra R Cook; Laura Vincent; Carolyn S Hall; Cecilia Martin; Anthony Lucci
Journal:  J Surg Res       Date:  2010-03-26       Impact factor: 2.192

4.  HGF/scatter factor selectively promotes cell invasion by increasing integrin avidity.

Authors:  L Trusolino; S Cavassa; P Angelini; M Andó; A Bertotti; P M Comoglio; C Boccaccio
Journal:  FASEB J       Date:  2000-08       Impact factor: 5.191

5.  Effects of transferred NK4 gene on proliferation, migration, invasion and apoptosis of human prostate cancer DU145 cells.

Authors:  Dan Yue; Yong Wang; Ping Ma; Yin-Yan Li; Hong Chen; Ping Wang; Chang-Shan Ren
Journal:  Asian J Androl       Date:  2010-04-19       Impact factor: 3.285

Review 6.  NK4 gene therapy targeting HGF-Met and angiogenesis.

Authors:  Kunio Matsumoto; Toshikazu Nakamura
Journal:  Front Biosci       Date:  2008-01-01

Review 7.  Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review).

Authors:  Randall E Harris; Joanne Beebe-Donk; Hani Doss; Deborah Burr Doss
Journal:  Oncol Rep       Date:  2005-04       Impact factor: 3.906

8.  Immunohistochemical expression of hepatocyte growth factor and c-Met/HGF receptor in benign and malignant human prostate tissue.

Authors:  Koh-Ichi Nakashiro; Yoshiki Hayashi; Ryoichi Oyasu
Journal:  Oncol Rep       Date:  2003 Sep-Oct       Impact factor: 3.906

9.  Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapy.

Authors:  Kacper Jankowski; Magda Kucia; Marcin Wysoczynski; Ryan Reca; Dongling Zhao; Ela Trzyna; John Trent; Stephen Peiper; Marek Zembala; Janina Ratajczak; Peter Houghton; Anna Janowska-Wieczorek; Mariusz Z Ratajczak
Journal:  Cancer Res       Date:  2003-11-15       Impact factor: 12.701

10.  Hepatocyte growth factor inhibits anoikis by induction of activator protein 1-dependent cyclooxygenase-2. Implication in head and neck squamous cell carcinoma progression.

Authors:  Qinghua Zeng; Laurie K McCauley; Cun-Yu Wang
Journal:  J Biol Chem       Date:  2002-10-18       Impact factor: 5.157

View more
  18 in total

1.  Overexpression of Cpg15 Alleviates the Oxidative Stress in Neuronal Cells Via Regulating Redox Enzymes and Nrf2 Antioxidative Pathway.

Authors:  Yi Jiang; Jun-Jie Li; Ya-Wei Mu; Han-Yang Jiang; Zi-Xuan Wei; Zi-Yao Xiao; Jing-Jing Zhao; Xian-Hua Chen
Journal:  Neurotox Res       Date:  2022-01-17       Impact factor: 3.911

2.  Overexpression of hepatocyte growth factor protects chronic myeloid leukemia cells from apoptosis induced by etoposide.

Authors:  Xiaojiao Zheng; Shixuan Hua; Hang Zhao; Zhou Gao; Dong Cen
Journal:  Oncol Lett       Date:  2022-02-15       Impact factor: 2.967

3.  Vitamin E relieves chronic obstructive pulmonary disease by inhibiting COX2-mediated p-STAT3 nuclear translocation through the EGFR/MAPK signaling pathway.

Authors:  Hui Zhao; Jiannan Gong; Lifang Li; Shuyin Zhi; Guang Yang; Pingping Li; Ruina Li; Jianqiang Li
Journal:  Lab Invest       Date:  2021-11-19       Impact factor: 5.662

4.  Macrocyclic Inhibitors of HGF-Activating Serine Proteases Overcome Resistance to Receptor Tyrosine Kinase Inhibitors and Block Lung Cancer Progression.

Authors:  Vishnu C Damalanka; Jorine J L P Voss; Matthew W Mahoney; Tina Primeau; Shunqiang Li; Lidija Klampfer; James W Janetka
Journal:  J Med Chem       Date:  2021-12-13       Impact factor: 8.039

5.  Stromal cell diversity associated with immune evasion in human triple-negative breast cancer.

Authors:  Sunny Z Wu; Daniel L Roden; Chenfei Wang; Holly Holliday; Kate Harvey; Aurélie S Cazet; Kendelle J Murphy; Brooke Pereira; Ghamdan Al-Eryani; Nenad Bartonicek; Rui Hou; James R Torpy; Simon Junankar; Chia-Ling Chan; Chuan En Lam; Mun N Hui; Laurence Gluch; Jane Beith; Andrew Parker; Elizabeth Robbins; Davendra Segara; Cindy Mak; Caroline Cooper; Sanjay Warrier; Alistair Forrest; Joseph Powell; Sandra O'Toole; Thomas R Cox; Paul Timpson; Elgene Lim; X Shirley Liu; Alexander Swarbrick
Journal:  EMBO J       Date:  2020-08-13       Impact factor: 11.598

6.  c-MET as a Potential Resistance Mechanism to Everolimus in Breast Cancer: From a Case Report to Patient Cohort Analysis.

Authors:  Valentin Van den Bossche; Gaspard Jadot; Guillaume Grisay; Julien Pierrard; Natasha Honoré; Bénédicte Petit; David Augusto; Sébastien Sauvage; Jean-François Laes; Emmanuel Seront
Journal:  Target Oncol       Date:  2020-02       Impact factor: 4.864

7.  Zebularine Promotes Hepatic Differentiation of Rabbit Bone Marrow Mesenchymal Stem Cells by Interfering with p38 MAPK Signaling.

Authors:  Yong-Heng Luo; Juan Chen; En-Hua Xiao; Qiu-Yun Li; Yong-Mei Luo
Journal:  Stem Cells Int       Date:  2018-10-10       Impact factor: 5.443

8.  2'-Hydroxyflavanone induced changes in the proteomic profile of breast cancer cells.

Authors:  Lokesh D Nagaprashantha; Jyotsana Singhal; Shireen Chikara; Gabriel Gugiu; David Horne; Sanjay Awasthi; Ravi Salgia; Sharad S Singhal
Journal:  J Proteomics       Date:  2018-09-21       Impact factor: 4.044

9.  Crizotinib induced antitumor activity and synergized with chemotherapy and hormonal drugs in breast cancer cells via downregulating MET and estrogen receptor levels.

Authors:  Nehad M Ayoub; Dalia R Ibrahim; Amer E Alkhalifa; Belal A Al-Husein
Journal:  Invest New Drugs       Date:  2020-08-24       Impact factor: 3.850

Review 10.  Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities.

Authors:  Yazhuo Zhang; Mengfang Xia; Ke Jin; Shufei Wang; Hang Wei; Chunmei Fan; Yingfen Wu; Xiaoling Li; Xiayu Li; Guiyuan Li; Zhaoyang Zeng; Wei Xiong
Journal:  Mol Cancer       Date:  2018-02-19       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.